171623-29-3

Basic information

• Product Name: 4-Cyclopentyl-benzeneMethanol
• Synonyms: 4-Cyclopentyl-benzeneMethanol;(4-Cyclopentylphenyl)Methanol
• CAS NO: 171623-29-3
• Molecular Formula: C₁₂H₁₆O
• Molecular Weight: 176.25484
• Mol File: 171623-29-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 312.7±11.0 °C(Predicted)
• Appearance: /
• Density: 1.057±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 14.48±0.10(Predicted)
• CAS DataBase Reference: 4-Cyclopentyl-benzeneMethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Cyclopentyl-benzeneMethanol(171623-29-3)
• EPA Substance Registry System: 4-Cyclopentyl-benzeneMethanol(171623-29-3)

Safety Data

• Hazardous Substances Data: 171623-29-3(Hazardous Substances Data)

Usage

General Description

4-Cyclopentyl-benzeneMethanol, also known as 1-(4-cyclopentylphenyl)ethanol or 1-(4-cyclopentylphenyl)methanol, is a chemical compound with the molecular formula C13H16O. It is a colorless to pale yellow liquid that is used in various industrial applications, including as a solvent, intermediate in organic synthesis, and as a fragrance ingredient. 4-Cyclopentyl-benzeneMethanol is primarily synthesized through the reduction of 4-cyclopentylbenzophenone, and it has a mild, sweet, floral odor. It is important to handle this chemical with care, as it is flammable and can cause skin irritation and eye damage upon contact.

Upstream product

• 1122-91-4 4-bromo-benzaldehyde 
• 287944-10-9 2-cyclopent-1-enyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 137-43-9 Cyclopentyl bromide 
• 915016-86-3 1-(p-formylphenyl)cyclopentene 
• 99768-12-4 4-methoxycarbonylphenylboronic acid 
• 71-43-2 benzene 
• 85689-77-6 1-(4-cyclopentylphenyl)ethan-1-one 
• 19936-22-2 p-cyclopentylbenzoic acid 
• 700-88-9 cyclopentylbenzene 
• 160598-47-0 Methyl 4-cyclopentylbenzoate 

Downstream Products

• 40452-70-8 4-Cyclopentylbenzaldehyde 

Relevant articles and documents

COMPOUNDS AND METHOD OF USE

This present disclosure relates to compounds with ferroptosis inducing activity, a method of treating a subject with cancer with the compounds, and combination treatments with a second therapeutic agent.

CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS

Described herein are compounds and pharmaceutical compositions which inhibit N-acylethanolamine acid amidase (NAAA). Described herein are methods for synthesizing the compounds set forth herein and methods for formulating these compounds as pharmaceutical compositions which include these compounds. Also described herein are methods of inhibiting NAAA in order to sustain the levels of palmitoylethanolamide (PEA) and other N-acylethanolamines (NAE) that are substrates for NAAA, in conditions characterized by reduced concentrations of NAE. Also, described here are methods of treating and ameliorating pain, inflammation, inflammatory diseases, and other disorders in which modulation of fatty acid ethanolamides is clinically or therapeutically relevant or in which decreased levels of NAE are associated with the disorder.

Properties of the Liquid Crystals Formed by Ceratin Azomethines Derived from 4-Cycloalkylanilines and from 4-Cycloalkylbenzaldehydes

The liquid crystal behaviour of four homologous series of azomethines related to the nO.m series but containing a cycloalkyl group, is reported and discussed.Many of these compounds show extensive smectic polymorphism, one member of the nO.c6 series giving rise to five smectic polymorphic modofications for which phase type assignments have been made by thermal optical microscopy.Keywords: smectic polymorphism, azomethines, cycloalkyl derivatives